Emagix Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $39.5K
Latest Deal Amount
  • Investors
  • 3

Emagix General Information


Developer of algorithm-based analytics technology designed to be used for the diagnosis of retinal and brain vascular injury. The company's technology decreases the time required to capture images and identifies and quantifies critical information in the images, enabling physicians to conduct early diagnosis and follow-up treatment efficacy along with improved patient care and reduced clinical costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
  • 1344 Summer Street
  • Halifax, Nova Scotia
  • Canada
+1 (902) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Emagix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 07-Nov-2017 $39.5K Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. Grant 31-Oct-2016 $50K Completed Startup
To view Emagix’s complete valuation and funding history, request access »

Emagix Executive Team (4)

Name Title Board Seat Contact Info
Alon Friedman Ph.D Founder & Chief Executive Officer
Jim Trussler Chief Operating Officer
Jim Kukurin Chief Technology Officer
Natasha Sideris Chief Financial Officer
To view Emagix’s complete executive team members history, request access »

Emagix Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovacorp Venture Capital Minority 000 0000 000000 0
Atlantic Canada Opportunities Agency Government 000 0000 000000 0
BioNova Accelerator/Incubator Minority 000 0000 000000 0
To view Emagix’s complete investors history, request access »